Symptom burden and its effect on the quality of life in a selected group of breast cancer patients in Delta State (Nigeria) after chemotherapy: a cross-sectional study.

Key Points

• The research aims to explore how symptom burden influences the quality of life in breast cancer patients post-chemotherapy.
• Conducted a cross-sectional study among breast cancer patients in Delta State, Nigeria.
• Assessed symptom profiles and quality of life metrics after chemotherapy.
• Evaluated the relationship between symptom burden, social support, and treatment adherence.
• Identified a significant correlation between high symptom burden and reduced quality of life.
• Noted that advanced-stage patients experience greater symptom burden than those in earlier stages.
• Highlighted that lack of social support negatively affects treatment adherence and overall well-being.